Featured · Drug Pricing
The Preventable Peptide Crisis: Navigating GLP-1s and the Gray Market
In the latest episode of the Health Policy Podcast, host Bryan Hyde interviews Peter Pitts, President of the Center for Medicine in the Public Interest, about the rising popularity of GLP-1 medications for weight loss and the dangers of the gray market. Pitts discusses the health implications of using these drugs without medical supervision and the risks associated with counterfeit and unapproved medications. He emphasizes the importance of FDA oversight and urges consumers to consult healthcare professionals before seeking weight loss solutions online.
2026-10-08 · with Peter Pitts
